Synthaverse S.A. (WSE:SVE)
4.065
+0.035 (0.87%)
Jan 7, 2026, 5:00 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 285.21 million as of January 7, 2026. Its market cap has decreased by -1.01% in one year.
Market Cap
285.21M
Enterprise Value
372.39M
Revenue
71.76M
Ranking
n/a
PE Ratio
63.83
Stock Price
4.07
Market Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 285.21M, an increase of 98.06%. That is a compound annual growth rate of 4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 285.21M | 10.41% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.73B |
| Synektik Spólka Akcyjna | 2.44B |
| Voxel | 1.35B |
| Celon Pharma | 1.12B |
| Selvita | 805.81M |
| Ryvu Therapeutics | 635.80M |
| Centrum Medyczne ENEL-MED | 509.05M |